IBAFLIN 300MG TABLETS FOR DOGS

Land: Australia

Språk: engelsk

Kilde: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktiv ingrediens:

IBAFLOXACIN

Tilgjengelig fra:

INTERVET AUSTRALIA PTY LIMITED

INN (International Name):

ibafloxacin(300mg/Tb)

Legemiddelform:

ORAL TABLET

Sammensetning:

IBAFLOXACIN ANTIBIOTIC Active 300.0 mg/Tb

Enheter i pakken:

8 Tablets

Klasse:

VM - Veterinary Medicine

Produsert av:

INTERVET AUSTRALIA

Terapeutisk gruppe:

DOG | BITCH | CASTRATE | PUPPY

Terapeutisk område:

ANTIBIOTIC & RELATED

Indikasjoner:

INFECTIONS OF THE RESPIRATORY TRACT | INFECTIONS OF THE URINARY TRACTS | ORGANISMS SENSITIVE TO IBAFLOXACIN | PYODERMA | SOFT TISSUE INFECTIONS | ABSCESSES | ACUTE RESPIRATORY INFECTIONS | ANAL SACCULITIS | BRONCHISEPTICA | BRONCHITIS | ESCHERICHIA COLI | GINGIVITIS | GROUP D STREPTOCOCCUS | KLEBSIELLA SPP. | PHARYNGITIS | PNEUMONIA | POST-PARTURIENT INFECTIONS | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | PYODERMA | SEPTICAEMIA | STAPHYLOCOCCUS SPP. | TONSILLITIS

Produkt oppsummering:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, ORGANISMS SENSITIVE TO IBAFLOXACIN, PYODERMA, SOFT TISSUE INFECTIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, ORGANISMS SENSITIVE TO IBAFLOXACIN, PYODERMA, SOFT TISSUE INFECTIONS]; For the treatment of urinary tract, respiratory tract, skin & soft tissue infections sensitive to ibafloxacin in dogs.DO NOT USE in food producing species of animals. DO NOT USE in dogs with known fluoroquinone sensitivity or during period of rapid growth - see CONTRAINDICATIONS on product leaflet for details.

Autorisasjon status:

Registered

Autorisasjon dato:

2023-07-01

Informasjon til brukeren

59706-36594-8t-carton-txl-v3
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF THE REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
IBAFLIN
®
300 MG TABLETS FOR DOGS
ACTIVE CONSTITUENT:
IBAFLOXACIN 300 mg/tablet
For the treatment of urinary tract, respiratory tract, skin and soft
tissue infections
sensitive to ibafloxacin in Dogs.
8 Tablets
[Intervet Logo]
APPROVED
LABEL
Info
PEST


Verified
59706-36594-8t-carton-txl-v3
_ _
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE:
RESTRAINTS:
DO NOT USE in food producing species of animal.
FOR USE ONLY in dogs where indicated by antibiotic sensitivity testing
according to
principles of prudent use.
FIRST AID:
If poisoning occurs, contact a doctor or Poisons Information Centre.
Phone Australia
131126.
DISPOSAL:
Dispose of empty container by wrapping with paper and putting in
garbage.
STORAGE:
Store below 25
°
C (Air conditioning).
Batch No.:
Expiry Date:
APVMA Approval No.: 59706/8T/0708
INTERVET AUSTRALIA PTY LIMITED
91-105 Harpin Street
BENDIGO EAST VIC 3550
Phone: [phone]
APPROVED
LABEL
Batch:
IBAFLIN
®
300 mg
[Intervet logo]
IBAFLIN
®
300 mg
[Intervet logo]
Batch:
IBAFLIN
®
300 mg
[Intervet logo]
IBAFLIN
®
300 mg
[Intervet logo]
APPROVED
LABEL
59706-36594-8t-leaflet-txl-v3
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF THE REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
IBAFLIN
®
300 MG TABLETS FOR DOGS
ACTIVE CONSTITUENT:
IBAFLOXACIN 300 mg/tablet
For the treatment of urinary tract, respiratory tract, skin and soft
tissue infections
sensitive to ibafloxacin in Dogs.
INDICATIONS:
Conditions caused by pathogens sensitive to ibafloxacin:
Pyoderma (superficial and deep) – caused by sensitive pathogens such
as
_Staphylococci, Escherichia coli (E. coli)_ and _Proteus mirabilis_.
Soft tissue infections (wounds, abscesses, hot spots) caused by
sensitive pathogens
such as _Staphylococci, E. coli, Proteus mirabilis_ and
_Streptococci_.
Urinary tract infections caused by sensitive pathogens such as
_Staphylococci, _
_Proteus _spp_, Enterobacter_ spp_, E. coli_ and _K

Preparatomtale

PRODUCT NAME: IBAFLIN 300MG TABLETS FOR DOGS
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JANUARY, 2010
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
CHEMICAL NATURE:
Ibafloxacin is a synthetic antimicrobial substance of the
fluoroquinolone class.
TRADE NAME:
IBAFLIN 300MG TABLETS FOR DOGS
RECOMMENDED USE:
For the treatment of urinary tract, respiratory tract, skin and soft
tissue infections sensitive
to Ibafloxacin in dogs.
APVMA NO:
59706
CREATION DATE:
January, 2010
THIS VERSION ISSUED:
January, 2010
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S22, S25. Do not breathe dust. Avoid contact with eyes.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Tabletted solid.
ODOUR:
No data; expected to be a yeasty odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. This is
an antibiotic preparation.
Any person with a history of allergies to this class of substances
should avoid all contact with this product as it may cause
sensitisation. This is a physiologically active product and so contact
should be minimised, especially if the user is taking a
form of medication, as interactions can sometimes give unexpected and
undesired results.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this p